1. A method for diagnosing an error associated with a software, the method comprising:
receiving a stack trace associated with the error;
fetching a source code associated with the received stack trace;
parsing the fetched source code associated with the received stack trace;
generating an abstract syntax tree (AST) based on the parsed fetched source code;
inserting at least one logging call into the generated abstract tree; and
recompiling the fetched source code based on the generated abstract tree with the at least one inserted logging call.
2. The method of claim 1, further comprising:
uploading the recompiled source code onto at least one deployment server.
3. The method of claim 1, wherein the receiving of the stack trace comprises creating a problem record associated with the received stack trace.
4. The method of claim 1, wherein the inserting at least one logging call comprises printing the at least one parsed object to a log file.
5. The method of claim 1, wherein the fetching the source code comprises pulling the fetched source code out of source control.
6. The method of claim 1, wherein the at least one logging call is configurable.
7. The method of claim 1, wherein the recompiled code is installed onto at least one device associated with a user of the software.
8. The method of claim 4, wherein the log file is uploaded to at least one developer’s system associated with the software.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A transgenic aloe plant comprising a recombinant DNA construct, said construct comprising a promoter, a sequence encoding an exogenous protein, a termination sequence, and a translocation sequence encoding a secretion signal peptide;
wherein the exogenous protein is a mammalian protein selected from interferons, immunoglobulins, mammalian growth factors, mammalian hormones, blood factors, and histocompatibility antigens;
the exogenous protein is expressed from the DNA construct; and
at least a portion of the exogenous protein is translocated from an aloe cell into the gel of an aloe leaf of the transgenic aloe plant;
wherein the promoter is a ubiquitin promoter from maize having SEQ ID No. 44; and the DNA construct contains at least one selectable marker gene.
2. A transgenic aloe plant comprising a recombinant DNA construct, the construct comprising a promoter, a sequence encoding an exogenous protein, a termination sequence, and a translocation sequence encoding a secretion signal peptide,
wherein the exogenous protein is a mammalian protein selected from interferons, immunoglobulins, lymphokines, mammalian growth factors, mammalian hormones, blood factors and histocompatibility antigens;
the exogenous protein is expressed from the DNA construct;
at least a portion of the exogenous protein is translocated from an aloe cell into the gel of an aloe leaf of the transgenic aloe plant; and
the promoter is a ubiquitin promoter from maize having SEQ ID No. 44.
3. The transgenic aloe plant of claim 2 wherein the exogenous protein is a mammalian protein selected from \u03b1-interferon, \u03b3-interferon, prothrombin, dermicidin and human growth hormone.
4. The transgenic aloe plant of claim 2 wherein the exogenous protein is \u03b1-interferon, \u03b3-interferon, or human growth hormone.
5. The transgenic aloe plant of claim 2 wherein the translocation sequence is the alpha amylase secretory sequence from rice.
6. The transgenic aloe plant of claim 5 wherein the translocation sequence is the alpha amylase secretory sequence from Oryza sativa rice having SEQ ID No. 29.
7. The transgenic aloe plant of claim 2 wherein the recombinant DNA construct has at least one enhancer element.
8. The transgenic aloe plant of claim 7 wherein the recombinant DNA construct has at least one selectable marker gene.
9. The transgenic aloe plant of claim 8 wherein the recombinant DNA construct has at least one selectable marker gene conferring resistance to a compound chosen from the group consisting of kanamycin, chloramphenicol, G418, hygromycin B, paromomycin, glufosinate, glyphosate and gentamycin.
10. The transgenic plant of claim 2 wherein the aloe plant is a species selected from the group consisting of Aloe vera, Aloe ferox and Aloe arboresence.
11. The transgenic aloe plant of claim 2 wherein the recombinant DNA construct further comprises an expression cassette encoding eGFP, the expression cassette encoding eGFP having an internal ribosomal entry site and a termination sequence, wherein both the sequence encoding the exogenous protein and eGFP sequences are expressed as a single mRNA transcript.
12. The transgenic aloe plant of claim 11 wherein the sequence encoding an exogenous protein encodes for interferon.
13. The transgenic aloe plant of claim 2 wherein the recombinant DNA construct further comprises an expression cassette encoding a protein conferring resistance to kanamycin, the sequence encoding the protein conferring resistance to kanamycin having an internal ribosomal entry site and a termination sequence, wherein both the sequence encoding the exogenous protein and the kanamycin-resistant sequences are expressed as a single mRNA transcript.
14. The transgenic aloe plant of claim 13 wherein the sequence encoding an exogenous protein encodes for interferon.